Literature DB >> 3038836

Brain opioids and autism: an updated analysis of possible linkages.

T L Sahley, J Panksepp.   

Abstract

Considerable clinical evidence suggests that autistic children lack the normal ability or desire to engage others socially, as indicated by their poor social skills and inappropriate use of language for communicative purposes. Specifically, these children seem to lack normal amounts of social-emotional interest in other people, leading perhaps to a decreased initiative to communicate. This paper summarizes experimental evidence supporting a neurological theory, which posits that autism, at least partially, represents in the brain, such as brain opioids. These substances modulate social-emotional processes, and the possibility that blockade of opioid activity in the brain may be therapeutic for early childhood autism is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038836     DOI: 10.1007/BF01495056

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  80 in total

1.  AROUSAL AND CHILDHOOD AUTISM.

Authors:  C HUTT; S J HUTT; D LEE; C OUNSTED
Journal:  Nature       Date:  1964-11-28       Impact factor: 49.962

2.  Evidence from auditory nerve and brainstem evoked responses for an organic brain lesion in children with autistic traits.

Authors:  M Student; H Sohmer
Journal:  J Autism Child Schizophr       Date:  1978-03

3.  Effects of fenfluramine on 14 outpatients with the syndrome of autism.

Authors:  E R Ritvo; B J Freeman; E Geller; A Yuwiler
Journal:  J Am Acad Child Psychiatry       Date:  1983-11

4.  Effects of fenfluramine on behavioral, cognitive, and affective disturbances in autistic children.

Authors:  G J August; N Raz; T D Baird
Journal:  J Autism Dev Disord       Date:  1985-03

5.  Opioids in mental illness: theories, clinical observations, and treatment possibilities.

Authors: 
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

6.  Effect of chronic neonatal morphine and naloxone on sensorimotor and social development of young rats.

Authors:  N Najam; J Panksepp
Journal:  Pharmacol Biochem Behav       Date:  1989-07       Impact factor: 3.533

7.  Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.

Authors:  S J Watson; P A Berger; H Akil; M J Mills; J D Barchas
Journal:  Science       Date:  1978-07-07       Impact factor: 47.728

8.  Sensorimotor functioning and communication in mute autistic children.

Authors:  F Curcio
Journal:  J Autism Child Schizophr       Date:  1978-09

9.  Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth.

Authors:  I S Zagon; P J McLaughlin
Journal:  Life Sci       Date:  1984-11-12       Impact factor: 5.037

10.  The effects of methadone on the social behavior and activity of the rat.

Authors:  M Plonsky; P R Freeman
Journal:  Pharmacol Biochem Behav       Date:  1982-04       Impact factor: 3.533

View more
  25 in total

1.  Does oxytocin deficiency mediate social deficits in autism?

Authors:  C Modahl; D Fein; L Waterhouse; N Newton
Journal:  J Autism Dev Disord       Date:  1992-09

2.  Brief report: a double-blind study of naltrexone in infantile autism.

Authors:  M Leboyer; M P Bouvard; J M Launay; F Tabuteau; D Waller; M Dugas; B Kerdelhue; P Lensing; J Panksepp
Journal:  J Autism Dev Disord       Date:  1992-06

3.  Brief report: plasma beta-endorphin and cortisol levels in autistic patients.

Authors:  C A Sandman; J L Barron; A Chicz-DeMet; E M DeMet
Journal:  J Autism Dev Disord       Date:  1991-03

4.  Brief report: a synopsis of an open-trial of naltrexone treatment of autism with four children.

Authors:  J Panksepp; P Lensing
Journal:  J Autism Dev Disord       Date:  1991-06

5.  Opioid receptors: binding that ties.

Authors:  Amy R Furay; John F Neumaier
Journal:  Neuropsychopharmacology       Date:  2011-10       Impact factor: 7.853

6.  Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children.

Authors:  Eric Rubenstein; Jessica C Young; Lisa A Croen; Carolyn DiGuiseppi; Nicole F Dowling; Li-Ching Lee; Laura Schieve; Lisa D Wiggins; Julie Daniels
Journal:  J Autism Dev Disord       Date:  2019-01

7.  CSF beta-endorphin levels in patients with infantile autism.

Authors:  S Nagamitsu; T Matsuishi; T Kisa; H Komori; M Miyazaki; T Hashimoto; Y Yamashita; E Ohtaki; H Kato
Journal:  J Autism Dev Disord       Date:  1997-04

8.  Tracking social motivation systems deficits: the affective neuroscience view of autism.

Authors:  Arnaud Carré; Coralie Chevallier; Laurence Robel; Caroline Barry; Anne-Solène Maria; Lydia Pouga; Anne Philippe; François Pinabel; Sylvie Berthoz
Journal:  J Autism Dev Disord       Date:  2015-10

9.  Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects.

Authors:  E H Cook; B D Perry; G Dawson; M S Wainwright; B L Leventhal
Journal:  J Autism Dev Disord       Date:  1993-03

10.  Pain reactivity and plasma beta-endorphin in children and adolescents with autistic disorder.

Authors:  Sylvie Tordjman; George M Anderson; Michel Botbol; Sylvie Brailly-Tabard; Fernando Perez-Diaz; Rozenn Graignic; Michèle Carlier; Gérard Schmit; Anne-Catherine Rolland; Olivier Bonnot; Séverine Trabado; Pierre Roubertoux; Guillaume Bronsard
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.